S N Ghaemi

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature
    S N Ghaemi
    Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry, George Washington University, Washington, DC, USA
    J Clin Psychopharmacol 19:354-61. 1999
  2. ncbi request reprint Cholesterol levels in mood disorders: high or low?
    S N Ghaemi
    Harvard Bipolar Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Bipolar Disord 2:60-4. 2000
  3. ncbi request reprint Does olanzapine have antidepressant properties? A retrospective preliminary study
    S N Ghaemi
    Harvard Bipolar Research Program, Massachusetts General Hospital, Consolidated Department of Psychiatry, Boston 02114, USA
    Bipolar Disord 2:196-9. 2000
  4. ncbi request reprint The treatment of bipolar depression
    G S Sachs
    Massachusetts General Hospital, Consolidated Department of Psychiatry, Harvard Medical School, Boston 02114, USA
    Bipolar Disord 2:256-60. 2000
  5. doi request reprint Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state
    C U Pae
    Department of Psychiatry, Duke University Medical Center, Durham, NC, USA
    Pharmacopsychiatry 45:152-5. 2012
  6. ncbi request reprint The emergency treatment of depression complicated by psychosis or agitation
    R L Glick
    Department of Psychiatry, University of Michigan Health System, Ann Arbor, USA
    J Clin Psychiatry 61:43-8. 2000
  7. ncbi request reprint Effectiveness and safety of long-term antidepressant treatment in bipolar disorder
    S N Ghaemi
    Consolidated Department of Psychiatry, Harvard Medical School, Boston, Mass, USA
    J Clin Psychiatry 62:565-9. 2001
  8. pmc Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks
    S N Ghaemi
    Mood Disorders Program, Department of Psychiatry, Tufts Medical Center, Boston, MA 02111, USA
    Acta Psychiatr Scand 118:347-56. 2008
  9. ncbi request reprint Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use
    S N Ghaemi
    Psychopharmacology Program, Cambridge Hospital, Consolidated Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA
    J Affect Disord 65:281-7. 2001
  10. ncbi request reprint Gabapentin treatment of the non-refractory bipolar spectrum: an open case series
    S N Ghaemi
    Psychopharmacology Program, Cambridge Hospital, Consolidated Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA
    J Affect Disord 65:167-71. 2001

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature
    S N Ghaemi
    Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry, George Washington University, Washington, DC, USA
    J Clin Psychopharmacol 19:354-61. 1999
    ..If randomized or double-blind data support the open-label data reviewed here, atypical antipsychotic agents may possess an important role in the adjunctive treatment of bipolar disorder...
  2. ncbi request reprint Cholesterol levels in mood disorders: high or low?
    S N Ghaemi
    Harvard Bipolar Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Bipolar Disord 2:60-4. 2000
    ..To assess cholesterol levels in patients with mood disorders...
  3. ncbi request reprint Does olanzapine have antidepressant properties? A retrospective preliminary study
    S N Ghaemi
    Harvard Bipolar Research Program, Massachusetts General Hospital, Consolidated Department of Psychiatry, Boston 02114, USA
    Bipolar Disord 2:196-9. 2000
    ..We sought to determine if olanzapine is effective in the add-on treatment of major affective disorders, particularly depressive symptoms, in a naturalistic setting...
  4. ncbi request reprint The treatment of bipolar depression
    G S Sachs
    Massachusetts General Hospital, Consolidated Department of Psychiatry, Harvard Medical School, Boston 02114, USA
    Bipolar Disord 2:256-60. 2000
    ..This paper reviews the available literature on the treatment of bipolar depression and offers recommendations for clinical management...
  5. doi request reprint Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state
    C U Pae
    Department of Psychiatry, Duke University Medical Center, Durham, NC, USA
    Pharmacopsychiatry 45:152-5. 2012
    ..The present study is aimed at investigating possible predictors of response to ziprasidone in a sample of patients with mixed depressive state...
  6. ncbi request reprint The emergency treatment of depression complicated by psychosis or agitation
    R L Glick
    Department of Psychiatry, University of Michigan Health System, Ann Arbor, USA
    J Clin Psychiatry 61:43-8. 2000
    ..This article will review relevant data and make recommendations for the emergency management of psychotic and agitated depressive syndromes...
  7. ncbi request reprint Effectiveness and safety of long-term antidepressant treatment in bipolar disorder
    S N Ghaemi
    Consolidated Department of Psychiatry, Harvard Medical School, Boston, Mass, USA
    J Clin Psychiatry 62:565-9. 2001
    ..We sought to review research on use of antidepressants for long-term treatment of bipolar depression...
  8. pmc Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks
    S N Ghaemi
    Mood Disorders Program, Department of Psychiatry, Tufts Medical Center, Boston, MA 02111, USA
    Acta Psychiatr Scand 118:347-56. 2008
    ..Long-term antidepressant (AD) treatment for depression in bipolar disorder (BPD) patients is highly prevalent, but its benefits and risks remain uncertain, encouraging this meta-analysis of available research...
  9. ncbi request reprint Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use
    S N Ghaemi
    Psychopharmacology Program, Cambridge Hospital, Consolidated Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA
    J Affect Disord 65:281-7. 2001
    ..Both agents, but particularly divalproex, demonstrated long-term antidepressant effects, with limited adjunctive standard antidepressant use...
  10. ncbi request reprint Gabapentin treatment of the non-refractory bipolar spectrum: an open case series
    S N Ghaemi
    Psychopharmacology Program, Cambridge Hospital, Consolidated Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA
    J Affect Disord 65:167-71. 2001
    ..To determine if gabapentin is effective in monotherapy or add-on treatment of non-refractory bipolar disorder in open prospective treatment...
  11. ncbi request reprint Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review
    J Sporn
    Department of Psychiatry, Massachusetts General Hospital, USA
    Ann Clin Psychiatry 12:137-40. 2000
    ..To assess the effectiveness and safety of pramipexole as an adjunctive medication in refractory bipolar and unipolar depression in a naturalistic setting...
  12. ncbi request reprint The impact of the discovery of lithium on psychiatric thought and practice in the USA and Europe
    F K Goodwin
    Department of Psychiatry, George Washington University, Washington, DC 20037, USA
    Aust N Z J Psychiatry 33:S54-64. 1999
    ..In addition, the development of lithium has demonstrated the closely intertwined purposes of clinical and basic research, and the continued importance of research in the clinical setting...
  13. doi request reprint A clinical predictive score for mood disorder risk in low-income primary care settings
    P A Vöhringer
    Hospital Clinico Universidad de Chile, Unidad de Trastornos del Ánimo, Clínica Psiquiátrica Universitaria, Facultad Medicina, Universidad de Chile, Santiago, Chile Mood Disorders Program, Tufts Medical Center, Boston, MA, United States Tufts University School of Medicine, Boston, MA, United States Graduate Program, Clinical and Translational Science Institute CTSI, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA, United States Electronic address
    J Affect Disord 151:1125-31. 2013
    ..This study aimed to develop a simplified clinical predictive score to help screen for presence of current mood disorder in low-income primary care settings...
  14. doi request reprint Affective temperaments in clinical practice: a validation study in mood disorders
    P A Vöhringer
    Mood Disorders Program, Department of Psychiatry, Tufts Medical Center, Tufts University School of Medicine, Boston, MA 02111, United States
    J Affect Disord 136:577-80. 2012
    ..We sought to examine correlations between clinical validators and temperaments in clinical practice...